GlassScriptPhysician profile
Robert C Stoler
NPI 1992779839
$587,001.08
in general payments reported to CMS, 2019-2025
32 companies · $65K in 2025
The $65K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121K · 2020: $86K · 2021: $60K · 2022: $71K · 2023: $74K · 2024: $110K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $84K · Travel and Lodging: $25K · Food and Beverage: $22K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Long Term Medical Supply Or Device Loan: $282 · Entertainment: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,331.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $84,050.00 |
| Travel and Lodging | $25,414.69 |
| Food and Beverage | $21,719.35 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,560.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Entertainment | $225.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $192,467.87 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Resolute Onyx |
| Boston Scientific Corporation | $181,726.04 | 2019-2025 | General - Vascular Access, General - Ct_ic, General - Therapies |
| Medtronic Vascular, INC. | $117,325.05 | 2019-2020 | |
| Biotronik INC. | $37,730.01 | 2019-2025 | Orsiro Mission, Nhancer Rx, Trapit |
| Abbott Laboratories | $21,564.61 | 2021-2025 | Portico, Optis, Herculink Elite |
| Edwards Lifesciences Corporation | $20,726.46 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Siemens Medical Solutions USA, INC. | $8,194.12 | 2019-2022 | |
| Shockwave Medical, INC | $2,705.55 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $1,605.37 | 2023-2025 | Manta, Guideliner, Turnpike |
| Cardiva Medical, INC. | $490.59 | 2019-2024 | Other, Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Spectrawave, INC | $332.28 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Penumbra, INC. | $295.93 | 2022-2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $240.17 | 2024-2025 | |
| Recor Medical INC | $231.69 | 2024 | Paradise Renal Denervation System |
| Cardiovascular Systems INC. | $225.16 | 2023 | Diamondback Coronary |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $225.10 | 2023 | Optowire |
| Ge Healthcare | $214.22 | 2024 | |
| Kaneka Medical America LLC | $180.79 | 2024 | |
| Corindus INC. | $125.38 | 2019 | |
| Abiomed | $99.32 | 2025 | |
| Terumo Medical Corporation | $66.05 | 2023-2025 | Metacross Otw, Angio-Seal, Tr Band |
| Depuy Synthes Sales INC. | $45.53 | 2025 | Matrixmidface |
| Tactile Systems Technology INC | $35.69 | 2023 | Flexitouch Plus, Entre Plus |
| Cathworks, INC. | $28.54 | 2024 | Ffrangio |
| Inari Medical, INC. | $25.32 | 2019 | |
| Saranas, INC. | $22.75 | 2023 | |
| Amgen INC. | $18.14 | 2024 | Repatha |
| Lantheus Medical Imaging, INC. | $15.78 | 2020 | |
| Itamar Medical INC | $13.13 | 2023 | Watchpatone |
| Novo Nordisk INC | $12.24 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.20 | 2023 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Stoler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.